30 April 1999
Effects of baclophen on the growth of 16/C transplantable mouse mammary adenocarcinoma (in vivo)
Maria Mazurkiewicz, Joanna Wietrzyk, Adam Opolski, Czesław Radzikowski, Zdzisław KleinrokMed Sci Monit 1999; 5(3): BR434-439 :: ID: 504762
Abstract
Described here is the protective effect of GABA receptor agonists (baclophen and muscimol) on the development of chemically induced digestive tract rodent tumors. The aim of this study was to evaluate the antitumor effect of baclophen administration on the growth of a transplantable mouse mammary cancer 16/C. All mice (C3H/W) were inoculated subcutaneously with 16/C tumor cells into the right flank region. Experimental group mice received baclophen in different doses (10mg/kg/day and 20mg/kg/day) and two different schedules. Control mice received a 0.9% NaCl solution only. Observations were carried out for a period of 22 days and tumor measurements were performed. The tumor volume was calculated by means of the formula (a2 x b)/2. Statistical analysis was performed by means of the t-Student's test. The difference was considered as significant when the p value was less than 0.05. We demonstrated an inhibitory effect of baclophen administration on the growth of transplantable mouse mammary cancer. This effect was dependent both on the dose and schedule of baclophen administration. Twenty mg/kg/day beginning 6 days before tumor implantation and ending on the 19th dayappeared to be the most effective treatment schedule. The mechanism of baclophen's antitumor effect remains unclear. We may consider baclophen's known effect on the hormonal system. It is also known that GABA and its agonists may influence some stages of neuroendocrine regulation. Moreover, there exists strong evidence that the GABA-ergic system is regulated by hormones. It is known that the mammary gland is affected by hormones, and breast cancer is classified as a hormone-dependent tumor.
Keywords: GAD, GABA, Baclophen, treatment
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
06 Mar 2024 : Clinical Research
Comparison of Outcomes between Single-Level and Double-Level Corpectomy in Thoracolumbar Reconstruction: A ...Med Sci Monit In Press; DOI: 10.12659/MSM.943797
21 Mar 2024 : Meta-Analysis
Economic Evaluation of COVID-19 Screening Tests and Surveillance Strategies in Low-Income, Middle-Income, a...Med Sci Monit In Press; DOI: 10.12659/MSM.943863
10 Apr 2024 : Clinical Research
Predicting Acute Cardiovascular Complications in COVID-19: Insights from a Specialized Cardiac Referral Dep...Med Sci Monit In Press; DOI: 10.12659/MSM.942612
06 Mar 2024 : Clinical Research
Enhanced Surgical Outcomes of Popliteal Cyst Excision: A Retrospective Study Comparing Arthroscopic Debride...Med Sci Monit In Press; DOI: 10.12659/MSM.941102
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952